VBLT - Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q3 2020 Results - Earnings Call Transcript

Vascular Biogenics Ltd. (VBLT) Q3 2020 Earnings Conference Call November 16, 2020 08:30 ET Company Participants Michael Wood - LifeSci Advisors Dror Harats - Chief Executive Officer Amos Ron - Chief Financial Officer Conference Call Participants Kevin DeGeeter - Oppenheimer Swayampakula Ramakanth - H.C. Wainwright Soumit Roy - Jones Trading Jonathan Aschoff - ROTH Capital Partners Jonathan Kreizman - Valore Research Presentation Operator Greetings. Welcome to VBL Therapeutics Third Quarter 2020 Earnings Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I would now like to turn over the conference to your host, Michael Wood, LifeSci Advisors. Thank you. You may begin. Michael Wood Thank you, Operator. Good morning and thank you, all, for participating in today's Third Quarter 2020 Results and Corporate Update for VBL Therapeutics. Leading the call this

For further details see:

Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q3 2020 Results - Earnings Call Transcript